Mirella Daja
The Annual Scientific Meeting of the Australian Diabetes Society and the Australian Diabetes Educators Association 2013
Days
Tuesday, 27th August
Wednesday, 28th August
Thursday, 29th August
Friday, 30th August
Tracks
Basic Science
Clinical Science
Invited
Search
Speakers
Mirella Daja
Abstracts this author is presenting:
Patients are more likely to reach A1c target at any given time during 26 weeks' treatment with liraglutide compared with both sitagliptin and exenatide
—
ADS Clinical Poster Discussions
Once daily liraglutide (1.2mg) vs twice daily exenatide (10ug) in the treatment of type 2 diabetes patients: a meta-analysis.
—
ADS Clinical Poster Discussions